Integra Lifesciences Holdings Corp (IART)

Cash & Short-Term Investments

$311.93M

Quarterly · Period ending: Sep 30, 2026 · USD

IART Cash & Short-Term Investments

Latest reported$311.93Mperiod endingSep 30, 2026

IART Quarterly Cash & Short-Term Investments ($7.20M → $311.93M)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

IART cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Integra Lifesciences Holdings Corp Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Sep 30, 2026	311,930,000
Jun 30, 2026	274,084,000
Mar 31, 2026	265,502,000
Dec 31, 2025	263,741,000
Sep 30, 2025	267,879,000
Jun 30, 2025	253,608,000
Mar 31, 2025	273,295,000
Dec 31, 2024	273,567,000
Sep 30, 2024	277,598,000
Jun 30, 2024	296,927,000
Mar 31, 2024	663,100,000
Dec 31, 2023	309,096,000
Sep 30, 2023	273,732,000
Jun 30, 2023	309,192,000
Mar 31, 2023	307,367,000
Dec 31, 2022	456,661,000
Sep 30, 2022	511,937,000
Jun 30, 2022	447,152,000
Mar 31, 2022	407,092,000
Dec 31, 2021	513,448,000
Sep 30, 2021	470,231,000
Jun 30, 2021	397,414,000
Mar 31, 2021	408,976,000
Dec 31, 2020	470,166,000
Sep 30, 2020	396,279,000
Jun 30, 2020	360,981,000
Mar 31, 2020	357,712,000
Dec 31, 2019	198,911,000
Sep 30, 2019	207,981,000
Jun 30, 2019	176,084,000
Mar 31, 2019	157,025,000
Dec 31, 2018	138,838,000
Sep 30, 2018	205,991,000
Jun 30, 2018	183,771,000
Mar 31, 2018	189,396,000
Dec 31, 2017	174,935,000
Sep 30, 2017	481,943,000
Jun 30, 2017	154,600,000
Mar 31, 2017	135,399,000
Dec 31, 2016	102,055,000
Sep 30, 2016	107,598,000
Jun 30, 2016	86,803,000
Mar 31, 2016	77,086,000
Dec 31, 2015	48,132,000
Sep 30, 2015	79,311,000
Jun 30, 2015	131,296,000
Mar 31, 2015	79,871,000
Dec 31, 2014	71,994,000
Sep 30, 2014	140,231,000
Jun 30, 2014	137,160,000
Mar 31, 2014	129,038,000
Dec 31, 2013	120,614,000
Sep 30, 2013	118,868,000
Jun 30, 2013	98,636,000
Mar 31, 2013	89,691,000
Dec 31, 2012	96,938,000
Sep 30, 2012	125,718,000
Jun 30, 2012	114,785,000
Mar 31, 2012	112,422,000
Dec 31, 2011	100,808,000
Sep 30, 2011	110,991,000
Jun 30, 2011	137,279,000
Mar 31, 2011	104,354,000
Dec 31, 2010	128,763,000
Sep 30, 2010	82,832,000
Jun 30, 2010	93,618,000
Mar 31, 2010	81,674,000
Dec 31, 2009	71,891,000
Sep 30, 2009	106,747,000
Jun 30, 2009	138,717,000
Mar 31, 2009	185,630,000
Dec 31, 2008	183,546,000
Sep 30, 2008	109,339,000
Jun 30, 2008	77,338,000
Mar 31, 2008	199,013,000
Dec 31, 2007	57,339,000
Sep 30, 2007	129,498,000
Jun 30, 2007	120,838,000
Mar 31, 2007	29,329,000
Dec 31, 2006	22,697,000
Sep 30, 2006	24,322,000
Jun 30, 2006	33,950,000
Mar 31, 2006	86,180,000
Dec 31, 2005	127,216,000
Sep 30, 2005	135,782,000
Jun 30, 2005	98,454,000
Mar 31, 2005	76,468,000
Dec 31, 2004	100,810,000
Sep 30, 2004	73,391,000
Jun 30, 2004	68,381,000
Mar 31, 2004	106,170,000
Dec 31, 2003	108,546,000
Sep 30, 2003	115,474,000
Jun 30, 2003	145,669,000
Mar 31, 2003	129,152,000
Dec 31, 2002	98,861,000
Sep 30, 2002	104,315,000
Jun 30, 2002	101,707,000
Mar 31, 2002	89,716,000
Dec 31, 2001	66,701,000